Status:
UNKNOWN
Gram-negative Bacilli and MRSA Screening in ICU in China
Lead Sponsor:
Sir Run Run Shaw Hospital
Collaborating Sponsors:
University of Birmingham
Conditions:
Infections, Bacterial
Eligibility:
All Genders
1+ years
Brief Summary
Carbapenem-resistant Gram-negative bacilli \[Carbapenem-resistant Acinetobacter baumannii (CRAB), Carbapenem-resistant Klebsiella pneumoniae (CRKP), and Carbapenem-resistant Pseudomonas aeruginosa (CR...
Detailed Description
Based on the previous study, investigators plan to screen for CRKP, CRAB, CRPsA and MRSA isolates from ICU settings, medical workers and patients, and establish the CRKP, CRAB, CRPsA and MRSA genome a...
Eligibility Criteria
Inclusion
- Patients infected by CRAB isolated from throat swabs, rectal swabs, gastric tubes, tracheal intubations, tracheostomy tubes, and nasointestinal tubes
- Patients infected by CRKP isolated from throat swabs, rectal swabs, gastric tubes, tracheal intubations, tracheostomy tubes, and nasointestinal tubes
- Patients infected by CRPsA isolated from throat swabs, rectal swabs, gastric tubes, tracheal intubations, tracheostomy tubes, and nasointestinal tubes
- Patients infected by MRSA collected from throat swabs, rectal swabs, gastric tubes, tracheal intubations, tracheostomy tubes, and nasointestinal tubes
Exclusion
- Mixed infections of other pathogens
- Virus infections
- Other infections caused by other pathogens, such as fungus
Key Trial Info
Start Date :
August 6 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04310722
Start Date
August 6 2019
End Date
December 1 2020
Last Update
March 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sir Run Run Shaw Hospital
Hangzhou, Zhejiang, China, 310016